PT  - JOURNAL ARTICLE
AU  - Fan, F S Y
AU  - Chow, K M
AU  - Szeto, C C
AU  - Li, P K T
TI  - Hyperchloraemic metabolic acidosis
AID  - 10.1136/emj.2008.059923
DP  - 2008 Sep 01
TA  - Emergency Medicine Journal
PG  - 613--613
VI  - 25
IP  - 9
4099  - http://emj.bmj.com/content/25/9/613.short
4100  - http://emj.bmj.com/content/25/9/613.full
SO  - Emerg Med J2008 Sep 01; 25
AB  - Cholestyramine carries a risk of hyperchloraemic metabolic acidosis. Being cognisant of this drug-induced adverse event may reduce diagnostic delays. Emergency physicians should be alert about this condition, in particular among patients with pre-existing chronic kidney disease, or who are taking spironolactone.